Si-Bone (SIBN) Cash & Equivalents (2017 - 2026)

Si-Bone has reported Cash & Equivalents for 10 years, with the latest figure at $29.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 29.65% year-over-year to $29.0 million; the trailing twelve-month figure through Mar 2026 stood at $29.0 million (down 29.65% YoY), and the FY2025 full-year result was $33.5 million, down 4.08% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $29.0 million, down from $33.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $110.8 million in Q2 2023, with the low at $18.9 million in Q3 2022.
• Average Cash & Equivalents over 5 years is $34.3 million, with a median of $27.8 million recorded in 2025.
• Year-over-year, Cash & Equivalents surged 355.67% in 2023 and sank 76.92% in 2024.
• Tracing SIBN's Cash & Equivalents over 5 years: stood at $20.7 million in 2022, then surged by 60.6% to $33.3 million in 2023, then grew by 5.04% to $34.9 million in 2024, then retreated by 4.08% to $33.5 million in 2025, then dropped by 13.57% to $29.0 million in 2026.
• The last three Cash & Equivalents figures came in at $29.0 million (Q1 2026), $33.5 million (Q4 2025), and $26.5 million (Q3 2025), per Business Quant data.

Peer Comparison